Cargando…
Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labels
Consider a parallel group trial for the comparison of an experimental treatment to a control, where the second‐stage sample size may depend on the blinded primary endpoint data as well as on additional blinded data from a secondary endpoint. For the setting of normally distributed endpoints, we demo...
Autores principales: | Żebrowska, Magdalena, Posch, Martin, Magirr, Dominic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851240/ https://www.ncbi.nlm.nih.gov/pubmed/26694878 http://dx.doi.org/10.1002/sim.6848 |
Ejemplares similares
-
Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials
por: Magirr, Dominic, et al.
Publicado: (2016) -
Estimation after blinded sample size reassessment
por: Posch, Martin, et al.
Publicado: (2016) -
Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications
por: Graf, Alexandra C, et al.
Publicado: (2014) -
Sample size re-assessment leading to a raised sample size does not inflate type I error rate under mild conditions
por: Broberg, Per
Publicado: (2013) -
Squeezed thermal vacuum and the maximum scale for inflation
por: Gasperini, M., et al.
Publicado: (1993)